Number of Shares
393.00
Current Holdings Value*
$25,030.00
% of Portfolio
0.94%
Total Estimate Gain
$-42.47
% of Total Estimate Gain
-0.01%

MID-CAP VALUE PROFUND's BioMarin Pharmaceutical Inc Holding Summary

As of 2025-04-30, MID-CAP VALUE PROFUND held 393.00 shares of BioMarin Pharmaceutical Inc(BMRN), totaling $25,030.00. This investment constitutes 0.94% of their stock portfolio, and MID-CAP VALUE PROFUND now holds 0% of the outstanding BioMarin Pharmaceutical Inc(BMRN) stock.

The initial trade took place in 2024Q3. And since then MID-CAP VALUE PROFUND has made 2 purchases of BMRN, at an average price of $65.82, for a total of 6,404.00 shares. In addition, there have been 2 sales at an average price of $66.36 for 6,011.00 shares. Based on historical transaction data and BMRN's current price of $57.50, MID-CAP VALUE PROFUND's estimated gain on his BMRN holdings is $-42.47, reflecting a -0.01% gain to date.

MID-CAP VALUE PROFUND BMRN ($57.50) Holding Chart

MID-CAP VALUE PROFUND BMRN ($57.50) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1